Y-Biologics, Inc. (KOSDAQ:338840)

Y-Biologics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	444.33	9,083	20,535	12,614	16,873	33,389
Short-Term Investments	41,744	3,120	362.11	368.9	74.96	-
Trading Asset Securities	84.58	-	-	-	-	-
Cash & Short-Term Investments	42,273	12,204	20,898	12,983	16,948	33,389
Cash Growth	200.20%	-41.60%	60.97%	-23.40%	-49.24%	30.85%
Accounts Receivable	194.93	63.87	573.37	689.88	825.19	247.65
Other Receivables	57.64	27.78	21.97	0.67	317.93	107.58
Receivables	252.56	91.64	595.34	690.55	1,143	355.23
Prepaid Expenses	74.61	42.91	89.29	20.2	91.4	17.49
Other Current Assets	263.88	132.56	180.33	845.17	1,663	4,323
Total Current Assets	42,864	12,471	21,763	14,538	19,845	38,085
Property, Plant & Equipment	6,462	7,407	8,009	10,801	16,824	10,331
Long-Term Investments	344.43	-	-	-	-	-
Other Intangible Assets	365.64	223.37	247.18	316.56	279.35	349.01
Other Long-Term Assets	1,512	1,627	275.5	3,667	1,296	971.33
Total Assets	51,548	21,727	30,294	29,323	38,245	49,736
Accounts Payable	2.12	3.23	1.21	-	-	-
Accrued Expenses	194.69	243.31	205.33	224.38	352.99	190.42
Short-Term Debt	18,985	-	2,000	-	-	-
Current Portion of Long-Term Debt	-	500	-	4,528	2,336	-
Current Portion of Leases	103.18	153.57	192.47	223.39	516.5	250.91
Other Current Liabilities	17,653	262	508.83	3,569	3,003	9,647
Total Current Liabilities	36,938	1,162	2,908	8,545	6,209	10,089
Long-Term Debt	-	-	500	-	2,528	4,864
Long-Term Leases	59.1	125.19	200.01	188.1	574.62	232.97
Other Long-Term Liabilities	778.84	802.45	677.72	645.96	491.76	345.83
Total Liabilities	37,776	2,090	4,286	9,379	9,803	15,532
Common Stock	7,475	7,391	7,381	6,145	6,141	5,763
Additional Paid-In Capital	126,304	124,295	122,727	93,385	93,287	79,550
Retained Earnings	-127,201	-120,290	-113,849	-92,978	-74,173	-57,102
Comprehensive Income & Other	7,195	6,960	7,149	5,741	3,186	2,320
Total Common Equity	13,772	18,356	23,408	12,293	28,441	30,530
Shareholders' Equity	13,772	19,637	26,008	19,943	28,441	34,205
Total Liabilities & Equity	51,548	21,727	30,294	29,323	38,245	49,736
Total Debt	19,147	778.76	2,892	4,940	5,955	5,348
Net Cash (Debt)	23,126	11,425	18,005	8,043	10,992	28,041
Net Cash Growth	73.71%	-36.55%	123.86%	-26.83%	-60.80%	39.85%
Net Cash Per Share	1557.05	764.89	1438.09	654.40	903.42	2810.07
Filing Date Shares Outstanding	14.97	14.78	14.76	12.29	12.17	9.98
Total Common Shares Outstanding	14.97	14.78	14.76	12.29	12.17	9.98
Working Capital	5,926	11,309	18,855	5,993	13,636	27,997
Book Value Per Share	920.23	1241.72	1585.65	1000.22	2337.50	3059.56
Tangible Book Value	13,407	18,132	23,161	11,977	28,162	30,181
Tangible Book Value Per Share	895.80	1226.61	1568.90	974.46	2314.54	3024.59
Land	749.16	749.16	594.79	594.79	594.79	594.79
Buildings	4,326	4,326	3,370	3,370	3,370	3,370
Machinery	10,714	10,580	10,479	12,144	11,635	5,245
Construction In Progress	353.61	317.23	377.82	301.48	3,703	3,556

Source: S&P Global Market Intelligence. Standard template. Financial Sources.